Cleanoze® Irrigation Device With Powder Preparation Versus Conventional Irrigation Method for Chronic Rhinitis
Primary Purpose
Rhinitis
Status
Completed
Phase
Phase 3
Locations
Thailand
Study Type
Interventional
Intervention
Cleanoze®
Saline (Syringe irrigation)
Sponsored by
About this trial
This is an interventional treatment trial for Rhinitis focused on measuring rhinitis
Eligibility Criteria
Inclusion Criteria:
- Any patients with chronic rhinitis conditions regardless of any cause (e.g. allergic, irritant, infection)
Exclusion Criteria:
- Acute or chronic rhinosinusitis
- Acute nasopharyngitis (common cold)
- Patients with a tendency to aspirate such as cerebrovascular accident, cranio-facial diseases.
- Sinunasal, nasopharyngeal and skull base tumors
- Age under 5 years old.
- Cannot administer a saline irrigation under the assistant of a care giver.
Sites / Locations
- Department of Otolaryngology, Khonkaen University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Cleanoze®
Syringe irrigation
Arm Description
Cleanoze® consists of a powder made up of Sodium chloride and Sodium Bicarbonate. This powder when dissolved in 250 ml of water is closely resembles the content of a body fluid which normally baths the outside of the cells of the body. This fluid is isotonic solution. The patient will be instructed to use this isotonic solution for nasal irrigation daily.
Nasal irrigation using sterile 0.9% NaCl 250 ml by 20 ml syringe The patient will be instructed to use this isotonic solution for nasal irrigation daily.
Outcomes
Primary Outcome Measures
Satisfaction score
This score will be evaluated at the end of 1 month using using the satisfaction questionaire
Secondary Outcome Measures
The adherence to Cleanoze® devic
The adherence will be evaluated by the diary that the investigator given to the participants
The durability of the Cleanoze® device
The durability will be evaluated by inspecting the device at the end of 1 month period
The symptoms score of the patients
The symptoms score will be evaluated using the one-question VAS scale
The Sino-Nasal Outcome Test-22 Questionnaire (SNOT-22) score
The SNOT-22 score will be evaluated by using SNOT-22 questionnaire
Adverse events
The adverse events will be recorded in the case record form at follow-up time
Full Information
NCT ID
NCT02763241
First Posted
April 29, 2016
Last Updated
August 7, 2018
Sponsor
Khon Kaen University
Collaborators
Farmaline Co.,Ltd., Thailand
1. Study Identification
Unique Protocol Identification Number
NCT02763241
Brief Title
Cleanoze® Irrigation Device With Powder Preparation Versus Conventional Irrigation Method for Chronic Rhinitis
Official Title
Phase III Randomized Open-label Clinical Trial Comparing Cleanoze® Irrigation Device With Powder Preparation Versus Conventional Irrigation Method for Chronic Rhinitis
Study Type
Interventional
2. Study Status
Record Verification Date
August 2018
Overall Recruitment Status
Completed
Study Start Date
January 2016 (Actual)
Primary Completion Date
January 2018 (Actual)
Study Completion Date
January 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Khon Kaen University
Collaborators
Farmaline Co.,Ltd., Thailand
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The investigators proposed that the Cleanoze® is superior to the traditional nasal saline irrigation in term of the ease of use which will resulting in a better quality of life of the participants. This study will compared the efficacy, adverse reactions, complications and ease of use of Cleanoze® comparing with normal saline solution
Detailed Description
Cleanoze® consists of a powder made up of Sodium chloride and Sodium Bicarbonate. This powder when dissolved in 250 ml of water is closely resembles the content of a body fluid which normally baths the outside of the cells of the body. This fluid is isotonic solution.
The nasal saline irrigation is the common procedure for upper respiratory tract infection patients including chronic rhinitis. The physician usually order the normal saline with appropriate medication e.g. anti-histamines, nasal steroids and anti-biotics to treat this condition.
The investigators proposed that the Cleanoze® is superior to the traditional nasal saline irrigation in term of the ease of use which will resulting in a better quality of life of the participants. This study will compared the efficacy, adverse reactions, complications and ease of use of Cleanoze® comparing with normal saline solution.
Study Population: Any patients with chronic rhinitis (e.g. allergic rhinitis, vasomotor rhinitis) will be randomized to receive the study or control medication. The investigators will include the children 5 years and above which able to doing the lavage under the parents assistant or by them self.
Study Design: Phase III randomized controlled trial
Sample Size: Estimate from pilot study, the 71 patients per arm was estimated (142 participants totally).
Study Duration:
Duration of enrollment is 1 year.
The patients will be followed up to 1 months depend on the disease conditions.
The data analysis will take 3 additional months
The full report will complete after the data analysis within 3 months
The total of 1 year and 6 months period needed for this study.
Primary Objective: To compare the satisfaction of the patients using Cleanoze® versus conventional device
Secondary Objective(s):
The adherence to Cleanoze® device
The durability of the Cleanoze® device
The patient symptom score (VAS)
The SNOT-22 questionaire for evaluating the quality of life of the patients
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rhinitis
Keywords
rhinitis
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
115 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Cleanoze®
Arm Type
Experimental
Arm Description
Cleanoze® consists of a powder made up of Sodium chloride and Sodium Bicarbonate. This powder when dissolved in 250 ml of water is closely resembles the content of a body fluid which normally baths the outside of the cells of the body. This fluid is isotonic solution.
The patient will be instructed to use this isotonic solution for nasal irrigation daily.
Arm Title
Syringe irrigation
Arm Type
Active Comparator
Arm Description
Nasal irrigation using sterile 0.9% NaCl 250 ml by 20 ml syringe
The patient will be instructed to use this isotonic solution for nasal irrigation daily.
Intervention Type
Drug
Intervention Name(s)
Cleanoze®
Intervention Description
Cleanoze® consists of a powder made up of Sodium chloride and Sodium Bicarbonate. This powder when dissolved in 250 ml of water is closely resembles the content of a body fluid which normally baths the outside of the cells of the body. This fluid is isotonic solution.
Intervention Type
Drug
Intervention Name(s)
Saline (Syringe irrigation)
Intervention Description
Nasal irrigation using 250 ml normal saline pushing into the nostril by 20 ml syringe
Primary Outcome Measure Information:
Title
Satisfaction score
Description
This score will be evaluated at the end of 1 month using using the satisfaction questionaire
Time Frame
1 month
Secondary Outcome Measure Information:
Title
The adherence to Cleanoze® devic
Description
The adherence will be evaluated by the diary that the investigator given to the participants
Time Frame
1 month
Title
The durability of the Cleanoze® device
Description
The durability will be evaluated by inspecting the device at the end of 1 month period
Time Frame
1 month
Title
The symptoms score of the patients
Description
The symptoms score will be evaluated using the one-question VAS scale
Time Frame
1 month
Title
The Sino-Nasal Outcome Test-22 Questionnaire (SNOT-22) score
Description
The SNOT-22 score will be evaluated by using SNOT-22 questionnaire
Time Frame
1 month
Title
Adverse events
Description
The adverse events will be recorded in the case record form at follow-up time
Time Frame
1 month
10. Eligibility
Sex
All
Minimum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Any patients with chronic rhinitis conditions regardless of any cause (e.g. allergic, irritant, infection)
Exclusion Criteria:
Acute or chronic rhinosinusitis
Acute nasopharyngitis (common cold)
Patients with a tendency to aspirate such as cerebrovascular accident, cranio-facial diseases.
Sinunasal, nasopharyngeal and skull base tumors
Age under 5 years old.
Cannot administer a saline irrigation under the assistant of a care giver.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Patorn Piromchai, MD, MSc
Organizational Affiliation
Khon Kaen University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Otolaryngology, Khonkaen University
City
Muang
State/Province
Khonkaen
ZIP/Postal Code
40002
Country
Thailand
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Cleanoze® Irrigation Device With Powder Preparation Versus Conventional Irrigation Method for Chronic Rhinitis
We'll reach out to this number within 24 hrs